All Novo Nordisk news

5 hours ago Drugmakers pledge restraint, but prices will still soar - Brandon Sun
5 hours ago Drugmakers pledge restraint, but prices will still soar - Savannah Morning News
8 hours ago Drugmakers pledge restraint, but prices will still soar - Daily Record
8 hours ago Drugmakers pledge restraint, but prices will still soar - Chicago Tribune
8 hours ago Drugmakers pledge restraint, but prices will still soar - Hawaii News Now
8 hours ago Drugmakers pledge restraint, but prices will still soar - WGEM Quincy
9 hours ago Drugmakers pledge restraint, but prices will still soar - Orlando Sentinel
9 hours ago Drugmakers pledge restraint, but prices will still soar - Philly.com
9 hours ago Drugmakers pledge restraint, but prices will still soar - Sun-Sentinel
9 hours ago Drugmakers pledge restraint, but prices will still soar - WFTV 9 Orlando
9 hours ago Drugmakers pledge restraint, but prices will still soar - Daily Herald
14 hours ago NVO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 - Business Wire
16 hours ago Arsanis and Adimab Enter Into License Agreement to Target Respiratory Syncytial Virus (RSV) With Monoclonal Antibodies - Business Wire
4 days ago Lawsuit accuses three insulin manufacturers of conspiring together - Daily Mail
5 days ago Trump travel ban 2.0; U.S. troops in Syria and expensive insulin - CBS News
5 days ago Drug makers accused of conspiring to hike insulin prices - CBS News
8 days ago Where are all the new diabetes drugs? - Boston Globe
10 days ago NOVO NORDISK SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S – (NVO) - Business Wire
11 days ago United Kingdom Diabetes Care Devices Market Outlook to 2022: Glucose Monitoring and Insulin Delivery - Key players covered include LifeScan Inc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd - Business Wire
11 days ago United States Insulin Delivery Market Outlook to 2022: Key Players are Medtronic, Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk - Business Wire
12 days ago One of the next epidemic-level chronic diseases doesn't have any approved treatments — and it could 'swamp the system' - Business Insider
12 days ago One of the next epidemic-level chronic diseases doesn't have any approved treatments -- and it could 'swamp the system' - Business Insider Australia
13 days ago Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact The Firm - Business Wire
17 days ago Forget the doom and gloom, ours is a bright future, says Stephen Pollard - express
17 days ago Researchers develop new method that can rapidly profile resistome of gut microbial communities - News-Medical-Net
18 days ago Big Pharma's offer to Trump: Discounts when drugs don't work - Chicago Tribune
18 days ago The 50 Best Workplaces for Giving Back - Fortune
18 days ago In French bellwether city, scandal deepens election uncertainty - Reuters
19 days ago Denmark joins race to host EU drug agency instead of London after Brexit - FOX News
19 days ago Just 2 of the 13 Largest Drugmakers Have More Cash Than Debt -- Can You Guess Who They Are? - FOX Business
19 days ago Just 2 of the 13 Largest Drugmakers Have More Cash Than Debt -- Can You Guess Who They Are? - FOX Business
19 days ago Denmark joins race to host EU drug agency instead of London after Brexit - EuroNews
20 days ago Big Pharma's Offer To Trump: Discounts When Drugs Don't Work - Hartford Courant
20 days ago 10 ways healthcare companies are testing Instagram - PRWeek UK
21 days ago Big Pharma's offer to Trump: Discounts when drugs don't work - Orlando Sentinel
21 days ago Big Pharma's offer to Trump: discounts when drugs don't work - The Norwich Bulletin
21 days ago 10 ways healthcare companies are testing Instagram - PRWeek US
22 days ago Diabetes has become one of America’s most expensive diseases - The Sacramento Bee
22 days ago What happened to Trump's crusade to lower drug prices? - The Sacramento Bee
23 days ago What happened to Trump's crusade to lower drug prices? - Island Packet
24 days ago Novo Nordisk A/S Closes the Books on a Tough Year - FOX Business
24 days ago Novo Nordisk A/S Closes the Books on a Tough Year - FOX Business
24 days ago Study ties fat shaming to increased risk of metabolic problems - Eye Witness News
24 days ago European stocks dragged down by Deutsche results - The Irish Times
25 days ago Fat shaming only increases risk of metabolic issues - asianage
25 days ago Fat shaming makes struggle with obesity worse for people - Decclan Chronicle
25 days ago This CEO Thinks Trump's Drug Pricing Threats Are All Bark and No Bite - Fortune
25 days ago Good News and Bad News for MannKind Corporation - FOX Business
25 days ago Good News and Bad News for MannKind Corporation - FOX Business
25 days ago Trump Volatility Index has taken pharma companies on a wild ride - The Globe and Mail

Create a custom search

News search supports Google type search formatting and the use of complex boolean. Wrap terms in double quotes for exact phrase matching. Click + to add multiple news search terms to this topic.